-- Scott Roberts
TUESDAY, Feb. 21 (HealthDay News) -- Medtronic's Resolute
Integrity Drug-Eluting Stent has been approved by the U.S. Food and
Drug Administration for people with coronary artery disease (CAD),
the Minneapolis-based company said in a news release.
A stent is a hollow mesh tube used to prop open a narrowed
coronary vessel. Medtronic's Resolute Integrity DES is made from a
drug-coated polymer material and resembles a flexible spring,
The device performed strongly in clinical studies, including
among people with diabetes, a common contributor to CAD, Medtronic
CAD is the leading cause of death in the United States, killing
almost 500,000 people annually, the company said.
Medline Plus has more about
coronary artery disease.
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.
Copyright © EBSCO Publishing. All rights reserved.